EVENTS

Join our mailing list to stay informed about club events and news: 

UPCOMING EVENTS

1 day Face-to-face workshop of the Grenoble Drug Discovery event

 November 25th 2022 . Grenoble.

Preliminary Program

  • Jordi Mestres –  IMIM Hospital del Mar Research InstituteBarcelona, Spain.
  • Florence Mahuteau – Chemistry and Modeling for the Biology of Cancer Institut Curie – Université PSL – Orsay, France.
  • Didier Leroy – Medecine for Malaria Venture – Geneva, Switzerland.

If you want to present your work at this workshop please, send us a tittle and a 300-word abstract through our contact form https://grenobledrugdiscovery.fr/contact/

OTHERS

podcast TAmDeM "Training des AcadéMiques sur le DÉveloppement du Médicament"

La Fondation Maladies Rares avec la participation et le soutien de Sanofi Genzyme vous propose de suivre le podcast TAmDeM “Training des AcadéMiques sur le DÉveloppement du Médicament” pour comprendre les étapes de développement d’un médicament, de sa création dans un laboratoire académique à sa mise sur le marché par un industriel.

Il sera diffusé chaque mois sur vos applications d’écoute de musique : Apple Podcasts, Spotify, Google Podcasts, Amazon Music, Deezer.

Pour en savoir plus : https://evenements-fondation-maladiesrares.org/event/podcast-tandem/

PAST EVENTS

Third Grenoble Drug Discovery Event

 April 13th 2022 (13:00 am 15:30). VIRTUAL EVENT.

Program

  • 13:00 – 13:30: “Rational antitubulin drug design” – Michel Steinmetz –  Paul Scherrer Institute – Villigen
  • 13:30 – 14:00: “Machine learning for early stage drug discovery” – Charlotte Deane – University of Oxford – Oxford
  • 14:00 – 14:15: “DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma” – Zuzzana Macekjilkova – CHU – Grenoble
  • 14:15 – 14:20: Pause
  • 14:30 14:45: “Engineering sialylated lipid nanoparticles toward a new cure for Influenza” – Paul Rivolier – CERMAV – Grenoble
  • 14:45 – 15:00: “New fluorophore emitting in the NIR-II for image-guided surgery” – Lucy Sancey – IAB – Grenoble
  • 15:00 – 15:30: “Exploring fungal BET inhibitors as a potential new class of antifungal drugs” – Carlo Petosa – IBS – Grenoble

Second Grenoble Drug Discovery Event

 September 28th 2021 (9:00 am 11:00). VIRTUAL EVENT.

Invited speakers

  • 9:00 – 9:40: “Integrative Drug Discovery Targeting Protein-Protein Interactions” – Xavier Morelli – Cancer Research Center CRCM – Marseille
  • 9:40 – 10:20: “Structural insights into the mechanism of antivirals targeting influenza virus RNA-dependent RNA polymerase” – Stephen Cusack – EMBL – Grenoble
  • 10:20 – 10:40: “Automated Protein-to-Structure Pipelines for Drug Discovery “ – Irina CornaciuALPX s.a.s – Grenoble

Grenoble Drug Discovery Kick off Event

 May 18th 2021 (9:00 am 12:00). VIRTUAL EVENT.

Invited speakers

  • “Phenomics approaches to support antibacterial drug discovery” – Nelly Dubarry – Evotec ID SAS – Lyon
  • “Exploring new targets and chemical space with affinity selection-mass spectrometry” – Didier Roche – Edelris
  • “Discovering a first-in-class in the context of antimicrobial resistance :  from the concept to the clinic” – Benoit Deprez – University of Lille

Partner event: "Journée Scientifique du Médicament"

Theme: Vectorization and theranostic.

Free registration: http://dpm.univ-grenoble-alpes.fr/jsm

 June 10th 2021 (3:00 pm CET). VIRTUAL EVENT.June